Evidence map›Paper›PMID 41304486›Full record

ArticleToxics2025

Heavy Metal Content in Tattoo and Permanent Makeup Inks and European Standards-Is There Still a Health Risk?

Małgorzata Ćwieląg-Drabek, Joanna Furman, Klaudia Gut-Pietrasz

Abstract read
In one paragraph

Article in Toxics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Is tattooing associated with an increased risk of cancer? A systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Małgorzata Ćwieląg-DrabekDepartment of Environmental Health Risk Factors, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland.ORCID 0000-0002-4219-9949
Joanna FurmanDepartment of Environmental Health Risk Factors, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland.ORCID 0000-0002-6013-5105
Klaudia Gut-PietraszDepartment of Environmental Health, Faculty of Public Health in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland.ORCID 0000-0002-5421-5811

Funding

Medical University of Silesia PCN-1-062/N/0/Z
6 · The paper itself

Abstract

Tattoos and permanent makeup involve intradermal pigment deposition and may introduce toxic trace elements into the body. Despite increasing popularity, harmonized EU regulations on tattoo ink composition only came into force in 2022 under REACH. This study evaluated the chemical safety of 41 commercially available inks in the EU following the implementation of these restrictions. Twelve heavy metals were analyzed (Cd, Pb, As, Hg, Zn, Cu, Ni, Cr, Co, Sb, Se, Mn). Copper showed the highest concentrations (mean 1751 mg/kg; max 25,701 mg/kg), while cadmium was lowest (mean 0.13 mg/kg). Exceedances of EU limits were recorded for Ni (24 samples), As (20), Cr(VI) (16), Cu (10), Sb (8), Co (6), and Pb (5); mercury was not detected in any ink. Dermal exposure was modeled across three tattooing scenarios using SED, MoS, HQ, and LCR indicators. Unacceptable non-cancer risk (MoS < 100) was mainly associated with copper (up to 85.4% of products), with additional concerns for zinc and arsenic (~50% of samples in higher-use scenarios). HQ values > 1 were most frequent for Ni, Cr(VI), and Cu, affecting up to 68.3%, 43.9%, and 58.5% of inks, respectively. Lifetime cancer risk above 1 × 10

Indexed as

dermal exposureheavy metalspermanent makeuprisk assessmenttattoo

Identifiers

PMID41304486
PMCPMC12656104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.